Yehiel Tal

Yehiel Tal

Chief Executive Officer at COLLPLANT BIOTECHNOLOGIES LTD.

Net worth: 10 867 $ as of 2026-06-29

72 year
Health Technology
Producer Manufacturing
Consumer Services

Profile

Yehiel Tal is the founder of Regentis Biomaterials Ltd., founded in 2004, and served as Chief Executive Officer from 2004 to 2010.
Current jobs include Chief Executive Officer at CollPlant Ltd., Chairman & Chief Executive Officer at CollPlant Biotechnologies Ltd. since 2025, and Director at the International Society For Biofabrication since 2021.
Former jobs include Director-Business Development at Kulicke & Soffa Industries, Inc., Vice President-Sales & Marketing at Nextech Corp., Vice President-Business Development at ProChon Biotech Ltd., and VP-Marketing & Business Development at Orthoscan Technologies Ltd. Education includes undergraduate and graduate degrees from Technion-Israel Institute of Technology.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-18 31,137 ( 0.22% ) 10 867 $ 2026-06-29

Yehiel Tal active positions

CompaniesPositionStart
COLLPLANT BIOTECHNOLOGIES LTD. Chief Executive Officer 2009-12-31
Chief Executive Officer 2010-05-04
International Society For Biofabrication
Director/Board Member 2020-12-31

Former positions of Yehiel Tal

CompaniesPositionEnd
REGENTIS BIOMATERIALS LTD. Chief Executive Officer 2009-12-31
Orthoscan Technologies Ltd.
Sales & Marketing -
Corporate Officer/Principal -
Sales & Marketing -
KULICKE AND SOFFA INDUSTRIES, INC. Corporate Officer/Principal -
See the detail of Yehiel Tal's experience

Training of Yehiel Tal

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

28

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Producer Manufacturing

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Orthoscan Technologies Ltd.

International Society For Biofabrication